ROR1 CAR T
/ Miltenyi Biomedicine, Miltenyi Biotec
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
March 18, 2026
Armoring ROR1 CAR T cells with IL18 improves CAR T cell function and cytotoxicity against pancreatic cancer cell-lines in vitro and in vivo
(AACR 2026)
- "Tran TM et al. J Immunother Cancer 2024; 12(4)"
CAR T-Cell Therapy • IO biomarker • Preclinical • Oncology • Pancreatic Cancer • Solid Tumor • IL18 • LAG3 • ROR1
1 to 1
Of
1
Go to page
1